Browse our extensive catalog of high-quality chemicals for research and development.
| Product Name | Description | CAS Number | Molecular Formula | Molecular Weight | Description |
|---|---|---|---|---|---|
| rac-N-Nitrosonornicotine 1-N-Oxide | NNN-N-Oxide; 3-[(2RS)-1-Nitroso-2-pyrrolidinyl]-pyridine-1-oxide; | 1314916-69-2 | C9H11N3O2 | 193.2 | NNN-N-Oxide; 3-[(2RS)-1-Nitroso-2-pyrrolidinyl]-pyridine-1-oxide;
|
| rac-N-Nitrosonornicotine-d4 1-N-Oxide | NNN-d4-N-Oxide; 3-[(2RS)-1-Nitroso-2-pyrrolidinyl]-pyridine-d4-1-oxide | C9H7D4N3O2 | 197.23 | NNN-d4-N-Oxide; 3-[(2RS)-1-Nitroso-2-pyrrolidinyl]-pyridine-d4-1-oxide
| |
| 5 alpha/6 alpha-Hydroxy Lurasidone Hydrochloride (Mixture of Diastereomers) | [2(1R,2R),3a alpha,4 beta,(5/6)alpha,7 beta,7a alpha]-2-[[2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-(5/6)-hydroxy-4,7-methano-1H-isoindole-1,3(2H)-dione Hydrochloride; Lurasidone Metabolite M-9 Hydrochloride; | C28H37ClN4O3S | 545.14 | [2(1R,2R),3a alpha,4 beta,(5/6)alpha,7 beta,7a alpha]-2-[[2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-(5/6)-hydro... | |
| rac-N-Nitrosonornicotine-13C6 1-N-Oxide | NNN-13C6-N-Oxide; 3-[(2RS)-1-Nitroso-2-pyrrolidinyl]-pyridine-13C6-1-oxide | C3 13C6H11N3O2 | 199.16 | NNN-13C6-N-Oxide; 3-[(2RS)-1-Nitroso-2-pyrrolidinyl]-pyridine-13C6-1-oxide
| |
| N-Nitrosonornicotine-5-carboxylic Acid | 5-(1-Nitroso-2-pyrrolidinyl)-3-pyridinecarboxylic Acid; | 1076199-27-3 | C10H11N3O3 | 221.21 | 5-(1-Nitroso-2-pyrrolidinyl)-3-pyridinecarboxylic Acid;
|
| 5 alpha/6 alpha-Hydroxy Lurasidone-d8 Hydrochloride (Mixture of Diastereomers) | [2(1R,2R),3a alpha,4 beta,(5/6)alpha,7 beta,7a alpha]-2-[[2-[[4-(1,2-Benzisothiazol-3-yl)-1-(piperazinyl-d8)]methyl]cyclohexyl]methyl]hexahydro-(5/6)-hydroxy-4,7-methano-1H-isoindole-1,3(2H)-dione Hydrochloride; Lurasidone Metabolite M-9-d8 Hydrochloride; | C28H29D8ClN4O3S | 553.19 | [2(1R,2R),3a alpha,4 beta,(5/6)alpha,7 beta,7a alpha]-2-[[2-[[4-(1,2-Benzisothiazol-3-yl)-1-(piperazinyl-d8)]methyl]cyclohexyl]methyl]hexahydro-(5/6)-... | |
| (R,S)-N-Nitrosonornicotine-13C6 | 3-(1-Nitroso-2-pyrrolidinyl)pyridine-13C6; NNN-13C6 | C3 13C6H11N3O | 183.16 | 3-(1-Nitroso-2-pyrrolidinyl)pyridine-13C6; NNN-13C6
| |
| (R)-N-Nitrosonornicotine | 3-[(2R)-1-Nitroso-2-pyrrolidinyl]pyridine; (R)-3-(1-Nitroso-2-pyrrolidinyl)pyridine; | 61601-78-3 | C9H11N3O | 177.2 | 3-[(2R)-1-Nitroso-2-pyrrolidinyl]pyridine; (R)-3-(1-Nitroso-2-pyrrolidinyl)pyridine;
|
| (R)-N-Nitrosonornicotine-d4 | 3-[(2R)-1-Nitroso-2-pyrrolidinyl]pyridine-d4; (R)-3-(1-Nitroso-2-pyrrolidinyl)pyridine-d4; | C9H7D4N3O | 181.23 | 3-[(2R)-1-Nitroso-2-pyrrolidinyl]pyridine-d4; (R)-3-(1-Nitroso-2-pyrrolidinyl)pyridine-d4;
| |
| 5 beta/6 beta-Hydroxy Lurasidone Hydrochloride (Mixture of Diastereomers) | [2(1R,2R),3a alpha,4 beta,(5/6)beta,7 beta,7a alpha]-2-[[2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-(5/6)-hydroxy-4,7-methano-1H-isoindole-1,3(2H)-dione Hydrochloride; Lurasidone Metabolite M-8 Hydrochloride; | C28H37ClN4O3S | 545.14 | [2(1R,2R),3a alpha,4 beta,(5/6)beta,7 beta,7a alpha]-2-[[2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-(5/6)-hydrox... |
Page 7737 of 10017